GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Cyclically Adjusted Revenue per Share

BIO-key International (BIO-key International) Cyclically Adjusted Revenue per Share : $75.69 (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

BIO-key International's adjusted revenue per share for the three months ended in Sep. 2023 was $3.598. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $75.69 for the trailing ten years ended in Sep. 2023.

During the past 12 months, BIO-key International's average Cyclically Adjusted Revenue Growth Rate was -14.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -12.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -12.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of BIO-key International was 3.90% per year. The lowest was -27.60% per year. And the median was -10.40% per year.

As of today (2024-04-29), BIO-key International's current stock price is $1.58. BIO-key International's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was $75.69. BIO-key International's Cyclically Adjusted PS Ratio of today is 0.02.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BIO-key International was 2.71. The lowest was 0.02. And the median was 0.95.


BIO-key International Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for BIO-key International's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-key International Cyclically Adjusted Revenue per Share Chart

BIO-key International Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.51 118.41 104.42 94.09 80.19

BIO-key International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.14 80.19 77.82 76.84 75.69

Competitive Comparison of BIO-key International's Cyclically Adjusted Revenue per Share

For the Security & Protection Services subindustry, BIO-key International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-key International's Cyclically Adjusted PS Ratio Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BIO-key International's Cyclically Adjusted PS Ratio falls into.



BIO-key International Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BIO-key International's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=3.598/129.8595*129.8595
=3.598

Current CPI (Sep. 2023) = 129.8595.

BIO-key International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 10.581 98.326 13.974
201403 40.235 99.695 52.409
201406 11.853 100.560 15.307
201409 37.765 100.428 48.833
201412 26.444 99.070 34.663
201503 17.079 99.621 22.263
201506 59.816 100.684 77.149
201509 17.632 100.392 22.808
201512 43.947 99.792 57.188
201603 11.342 100.470 14.660
201606 10.947 101.688 13.980
201609 11.342 101.861 14.460
201612 42.450 101.863 54.117
201703 33.762 102.862 42.623
201706 20.159 103.349 25.330
201709 20.933 104.136 26.104
201712 58.750 104.011 73.350
201803 15.291 105.290 18.859
201806 9.468 106.317 11.565
201809 8.132 106.507 9.915
201812 17.680 105.998 21.660
201903 5.691 107.251 6.891
201906 7.429 108.070 8.927
201909 4.530 108.329 5.430
201912 5.350 108.420 6.408
202003 4.971 108.902 5.928
202006 2.117 108.767 2.528
202009 2.634 109.815 3.115
202012 2.452 109.897 2.897
202103 4.373 111.754 5.081
202106 2.296 114.631 2.601
202109 3.000 115.734 3.366
202112 2.159 117.630 2.383
202203 4.432 121.301 4.745
202206 4.327 125.017 4.495
202209 3.033 125.227 3.145
202212 3.838 125.222 3.980
202303 6.205 127.348 6.327
202306 3.850 128.729 3.884
202309 3.598 129.860 3.598

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


BIO-key International  (NAS:BKYI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BIO-key International's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.58/75.69
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BIO-key International was 2.71. The lowest was 0.02. And the median was 0.95.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


BIO-key International Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of BIO-key International's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-key International (BIO-key International) Business Description

Industry
Traded in Other Exchanges
N/A
Address
3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Executives
Michael W Depasquale director, officer: Co-Chief Executive Officer 1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan officer: See Remarks 411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams director 400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok director FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia director 15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel director C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd 10 percent owner 5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin director FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis director 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao director SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush, director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch officer: Chief Financial Officer PO BOX 588, DUNSTABLE MA 01827
John Schoenherr director C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803

BIO-key International (BIO-key International) Headlines

From GuruFocus